Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Nektar Therapeutics (NKTR)

NASDAQ

$74.22

$-2.20

(-2.88%)

Previous Close: ⁦$76.37⁩

Market Closed

Nektar Therapeutics (NKTR) Live Price Chart

Last updated: ⁦2026-09-07 23:29:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Nektar Therapeutics (NKTR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $74.22, with a market capitalization of $2.53B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $33.40 to $109.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.53B
Open	$74.67
Day's High	$1,670.40
Day's Low	$6.19
Previous Close	$76.37
Volume	530.22K
Average Volume	848.90K
P/E Ratio	--
52-Week High	$109.00
52-Week Low	$33.40
Dividend Yield	--
Earnings Date	--

Nektar Therapeutics (NKTR) Latest Closing Stock Price

Nektar Therapeutics (NKTR) last closed at $76.37 as of 2026-09-04 23:56:00, unchanged from the previous close of $76.37.

During the latest regular trading session, NKTR traded between $6.19 and $1,670.40, with a volume of 530.22K shares. The closing price was near the lower end and near the middle of its 52-week range.

Nektar Therapeutics (NKTR) 7-Day Stock Price Change

Over the past seven days, Nektar Therapeutics (NKTR) moved from $74.55 to $74.22, representing a decline of 0.45% ($0.33).

The stock traded between $70.00 and $76.63 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 469.76 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

NKTR 52-Week Price Position

Position in Range: 54.0%

52W Low$33.40

52W High$109.00

NKTR is currently trading at $74.22, placing it 54.0% of the way from its 52-week low of $33.40 to its 52-week high of $109.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Nektar Therapeutics (NKTR)?

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Nektar Therapeutics Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	63
Exchange	NASDAQ
Company Website	https://www.nektar.com

How to Buy Nektar Therapeutics (NKTR) Stock on MEXC

Eligible investors can buy real shares of Nektar Therapeutics (NKTR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NKTR and Place Your Order

Open the RealStocks trading page and search for NKTR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Nektar Therapeutics (NKTR) stock price today?

Nektar Therapeutics (NKTR) is currently trading at $ 74.22, down 2.82% ($2.16) from the previous close of $ 76.37. Intraday prices update in real time during regular trading hours.

2.Is NKTR stock going up or down today?

As of 2026-09-04 23:56:00, NKTR is trading at $ 74.22, down 2.82% ($2.16) from its previous close of $ 76.37. The stock has traded between $ 6.19 and $ 1,670.40 during today’s regular session. Past price movements do not guarantee future results.

3.What is NKTR pre-market price?

As of 2026-09-04 23:56:00, NKTR is trading at $ 75.65 in pre-market trading, down 0.95% ($0.73) from the previous close of $ 76.37. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NKTR after-hours price?

As of 2026-09-04 23:56:00, NKTR is trading at $ 73.88 in after-hours trading, down 3.26% ($2.49) from the regular-session close of $ 76.37. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NKTR stock trading now?

NKTR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NKTR sit relative to its 52-week high and low?

Over the past 52 weeks, NKTR has traded between a low of $ 33.40 and a high of $ 109.00. At $ 74.22, the stock is positioned 54.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Nektar Therapeutics in?

Nektar Therapeutics (NKTR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Nektar Therapeutics's market capitalization and where is it listed?

Nektar Therapeutics is listed on the NASDAQ exchange with a market capitalization of $ 2.53B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NKTR valued in terms of P/E ratio and EPS?

NKTR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.60. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Nektar Therapeutics pay a dividend?

Nektar Therapeutics pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.